Vert Asset Management LLC cut its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 8.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 297,762 shares of the real estate investment trust's stock after selling 27,381 shares during the quarter. Healthpeak Properties accounts for about 1.9% of Vert Asset Management LLC's investment portfolio, making the stock its 17th largest holding. Vert Asset Management LLC's holdings in Healthpeak Properties were worth $5,214,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Healthpeak Properties by 584.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock valued at $186,405,000 after acquiring an additional 7,872,150 shares in the last quarter. Nuveen LLC bought a new stake in shares of Healthpeak Properties during the first quarter valued at approximately $124,113,000. Invesco Ltd. increased its position in shares of Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the period. Goldman Sachs Group Inc. boosted its stake in Healthpeak Properties by 57.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust's stock valued at $136,785,000 after buying an additional 2,477,307 shares in the last quarter. Finally, Amundi boosted its stake in Healthpeak Properties by 89.4% in the 1st quarter. Amundi now owns 5,047,699 shares of the real estate investment trust's stock valued at $98,228,000 after buying an additional 2,382,657 shares in the last quarter. Institutional investors own 93.57% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have commented on the company. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a research note on Monday, September 15th. Scotiabank downgraded Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their price objective for the company from $21.00 to $19.00 in a report on Tuesday, July 29th. Wells Fargo & Company lowered their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a report on Wednesday, August 27th. Cantor Fitzgerald began coverage on Healthpeak Properties in a report on Wednesday. They set a "neutral" rating and a $20.00 price objective for the company. Finally, Robert W. Baird set a $21.00 price objective on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Eight research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.
View Our Latest Research Report on Healthpeak Properties
Insider Buying and Selling
In related news, CEO Scott M. Brinker bought 2,930 shares of the business's stock in a transaction on Thursday, July 31st. The shares were purchased at an average cost of $17.06 per share, with a total value of $49,985.80. Following the acquisition, the chief executive officer owned 210,416 shares of the company's stock, valued at $3,589,696.96. This represents a 1.41% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders bought 8,783 shares of company stock worth $150,129. 0.23% of the stock is currently owned by insiders.
Healthpeak Properties Trading Up 0.3%
Shares of DOC stock opened at $19.21 on Thursday. The firm has a market capitalization of $13.35 billion, a P/E ratio of 80.02, a P/E/G ratio of 2.47 and a beta of 1.09. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock's fifty day simple moving average is $17.82 and its 200 day simple moving average is $18.05.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The business's quarterly revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently announced a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a c) annualized dividend and a yield of 6.4%. Healthpeak Properties's payout ratio is presently 508.33%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
